Active Shortage

APO-TERIPARATIDE INJECTION

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-TERIPARATIDE INJECTION in Canada?

Yes. APO-TERIPARATIDE INJECTION 250MCG has an active shortage reported to Health Canada (last updated September 11, 2026).

Why is APO-TERIPARATIDE INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-TERIPARATIDE INJECTION be available again?

The manufacturer's estimated resolution date is October 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~32 days remaining (estimate)

Affected strength250MCG

Last updated2026-09-11

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

OSNUVO

AVIR PHARMA INC.

250MCG · DIN 02495589

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-TERIPARATIDE INJECTION

TEVA CANADA LIMITED

250MCG · DIN 02486423

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

YORVIPATH

PENDOPHARM DIVISION OF PHARMASCIENCE INC

168MCG · DIN 02565153

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-30

~32 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02498804

Strength

250MCG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

TERIPARATIDE

Tier

Unrated

Last Updated

2026-09-11

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244